An unusual case of hemoptysis: Pulmonary artery pseudoaneurysm secondary to a lung abscess

Hiroyuki Tanaka1, Junji Uraki2, Motoaki Tanigawa3

  • 1Department of Infectious Diseases, Japanese Red Cross Ise Hospital, 471-2, Funae, Ise, Mie, 516-8512, Japan.

Insights

Massive hemoptysis can stem from pulmonary artery pseudoaneurysms (PAPs). Transcatheter arterial embolization (TAE) effectively treated a PAP in a patient with a lung abscess, resolving severe bleeding.

Area of Science:

  • Cardiovascular Medicine
  • Pulmonology
  • Interventional Radiology

Background:

  • Massive hemoptysis is a life-threatening condition often linked to pulmonary artery pathologies.
  • Pulmonary artery pseudoaneurysms (PAPs) are rare but critical causes of severe bleeding.
  • Lung abscesses can predispose patients to vascular complications.

Observation:

  • A 93-year-old male with pneumonia and a subsequent lung abscess developed sudden massive hemoptysis.
  • Multi-detector computed tomography angiography (MDCTA) identified a pulmonary artery pseudoaneurysm within the lung abscess cavity.
  • The patient's hemoptysis ceased following treatment.

Findings:

  • Transcatheter arterial embolization (TAE) successfully occluded the pulmonary artery pseudoaneurysm and its feeding arteries.
  • MDCTA proved effective in diagnosing the PAP within the complex context of a lung abscess.
  • The patient experienced complete resolution of hemoptysis without recurrence post-embolization.

Implications:

  • Pulmonary artery pseudoaneurysms should be considered in the differential diagnosis of delayed massive hemoptysis in patients with lung abscesses.
  • MDCTA is a valuable tool for the diagnosis of PAPs in this clinical setting.
  • TAE offers a minimally invasive and effective treatment option for managing PAP-related massive hemoptysis.

Related Concept Videos

Pulmonary Embolism I: Introduction01:29

Pulmonary Embolism I: Introduction

Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...
190
Pneumothorax-II01:27

Pneumothorax-II

Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
479
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
74
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
1.0K
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
674